Pathophysiology of minimal change nephrotic syndrome and focal segmental glomerulosclerosis

Nephrology

Volumn 12, Issue SUPPL. 3, 2007, Pages

  Cho, Min Hyun ^a   Hong, Eun Hee ^a   Lee, Tae Ho ^a   Ko, Cheol Woo ^a,b  

^a Kyungpook National University School of Medicine   (South Korea)

^b Kyungpook National University Hospital   (South Korea)

Author keywords

Focal segmental glomerulosclerosis; Interleukin 8; Minimal change nephrotic syndrome; Tumour necrosis factor

Indexed keywords

STEROID;

CHRONIC KIDNEY FAILURE; CONFERENCE PAPER; CONVALESCENCE; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE SEVERITY; DRUG RESPONSE; EPITHELIUM CELL; GLOMERULOSCLEROSIS; GLOMERULUS BASEMENT MEMBRANE; GLOMERULUS FILTRATION; HUMAN; KIDNEY BIOPSY; MACROMOLECULE; MINIMAL CHANGE GLOMERULONEPHRITIS; MORPHOLOGICAL TRAIT; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEINURIA; RISK FACTOR;

ANIMALS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; NEPHROSIS, LIPOID;

EID: 35948973106     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2007.00875.x     Document Type: Conference Paper

References (26)

1. A Report of the International Study of Kidney Disease in Children: The Primary nephrotic syndrome in children: Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. J. Pediatr. 1981 98 : 561 4.
2. Sewell RF, Short CD. Minimal-change nephropathy: How does the immune system affect the glomerulus? Nephrol. Dial. Transplant. 1993 8 : 108 12.
3. Koyama A, Fujisaki M, Kobayashi M et al. A glomerular permeability factor produced by human T cell hybridomas. Kidney Int. 1991 40 : 453 60.
4. Guasch A, Deen WM, Myers BD. Charge selectivity of the glomerular filtration barrier in healthy and nephrotic humans. J. Clin. Invest. 1993 92 : 2274 82.
5. Guasch A, Hashimoto H, Sibley RK et al. Glomerular dysfunction in nephrotic humans with minimal changes or focal glomerulosclerosis. Am. J. Physiol. 1991 260 : F728 37.
6. Wilkinson AH, Gillespie C, Hartley B et al. Increase in proteinuria and reduction in number of anionic sites in the glomerular basement membrane in rabbits by infusion of human nephrotic plasma in vivo. Clin. Sci. (Colch) 1989 77 : 43 8.
7. Zimmerman SW. Increased urinary protein excretion in the rat produced by serum from a patient with recurrent focal glomerular sclerosis after renal transplantation. Clin. Nephrol. 1984 22 : 32 8.
8. Boulton Jones JM, Tulloch I, Dore B et al. Changes in the glomerular capillary wall induced by lymphocyte products and serum of nephrotic patients. Clin. Nephrol. 1983 20 : 72 7.
9. Yoshizawa N, Kusumi Y, Matsumoto K et al. Studies of a glomerular permeability factor in patients with minimal-change nephrotic syndrome. Nephron 1989 51 : 370 6.
10. Mayurama K, Tomizawa S, Shimabukuro N et al. Effect of supernatants derived from T lymphocyte culture in minimal change nephrotic syndrome on rat kidney capillaries. Nephron 1989 51 : 73 6.
11. Tanaka R, Yoshikawa N, Nakamura H et al. Infusion of peripheral blood mononuclear cell products from nephrotic children increases albuminuria in rats. Nephron 1992 60 : 35 41.
12. Cheung PK, Dejkhuis FWJ, Bakker WW. The endothelial cell as potential target for a human vasoactive plasma factor associated with minimal change nephritic syndrome [Abstract]. J. Am. Soc. Nephrol. 1995 6 : 656.
13. Dantal J, Baatard R, Hourmant M, Cantarovich D, Buzelin F, Soulillou JP. Recurrent nephrotic syndrome following renal transplantation in patients with focal glomerulosclerosis. A one-center study of plasma exchange effects. Transplantation 1991 52 : 827 31.
14. Ko CW, Koo JH, Chang HJ et al. Permeability factor which was drawn from children with minimal change disease reversibly suppresses glomerular basement membrane heparin sulfate proteoglycan mRNA expression in rats glomerular epithelial cells [Abstract]. J. Am. Soc. Nephrol. 1999 10 : 106A.
15. Garin EH, Blanchard DK, Matsushima K et al. IL-8 production by peripheral blood mononuclear cells in nephrotic patients. Kidney Int. 1994 45 : 1311 17.
16. Neuhaus TJ, Wadhwa M, Callard R et al. Increased IL2, IL4 and interferon-gamma (IFN γ) in steroid-sensitive nephrotic syndrome. Clin. Exp. Immunol. 1995 100 : 475 9.
17. Bustos C, Gonzales E, Muley R et al. Increase of tumor necrosis factor alpha synthesis and gene expression in peripheral blood mononuclear cells of children with idiopathic nephritic syndrome. Eur. J. Clin. Invest. 1994 24 : 799 805.
18. Kallunki P, Tryggvason K. Human basement membrane heparan sulfate proteoglycan core protein: A 467 kd protein containing multiple domains resembling elements of the low density lipoprotein receptor, laminin, neural cell adhesion molecule and epidermal growth factor. J. Cell Biol. 1992 116 : 559 71.
19. Cheung PK, Klok PA, Baller JF et al. Induction of experimental proteinuria in vivo following infusion of human plasma hemopexin. Kidney Int. 2000 57 : 1512 20.
20. Garin EH. Effect of lipoid nephrosis cytokine on glomerular sulfated compounds and albuminuria. Pediatr. Nephrol. 1995 9 : 587 93.
21. Nakanishi I, Montabarrick A, Okada N et al. Interleukin-8 in chronic renal failure and dialysis patients. Nephrol. Dial. Transplant. 1994 9 : 1435 42.
22. Wada T, Yokoyama H, Tomosugi N et al. Detection of urinary interleukin-8 in glomerular diseases. Kidney Int. 1994 46 : 455 60.
23. Cho MH, Lee HS, Choe BH et al. Interleukin-8 and tumor necrosis factor-alpha are increased in minimal change disease but do not alter albumin permeability. Am. J. Nephrol. 2003 23 : 260 6.
24. Guasch A, Hashimoto H, Sibley RK, Deen WM, Myers BD. Glomerular dysfunction in nephrotic humans with minimal changes or focal glomerulosclerosis. Am. J. Physiol. 1991 60 : F728 37.
25. A report of Southwest Pediatric Nephrology Study Group: Childhood nephrotic syndrome associated with diffuse mesangial hypercellularity. Kidney Int. 1983 24 : 87 94.
26. Fogo A, Hawkins EP, Berry PL et al. Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerular sclerosis. Kidney Int. 1990 38 : 115 23.